Piedmont Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-120,529
Closed -$12M 941
2019
Q3
$12M Buy
120,529
+4,586
+4% +$436K 0.46% 47
2019
Q2
$10.7M Sell
115,943
-260
-0.2% -$24.7K 0.43% 46
2019
Q1
$11M Buy
116,203
+24,589
+27% +$2.15M 0.44% 45
2018
Q4
$5.87M Buy
91,614
+3,663
+4% +$270K 0.28% 96
2018
Q3
$7.87M Buy
87,951
+56,997
+184% +$5.04M 0.33% 81
2018
Q2
$2.46M Sell
30,954
-81,085
-72% -$6.73M 0.12% 183
2018
Q1
$9.99M Sell
112,039
-54,665
-33% -$5.25M 0.27% 100
2017
Q4
$17.4M Sell
166,704
-536
-0.3% -$60.5K 0.35% 72
2017
Q3
$24.4M Buy
167,240
+1,544
+0.9% +$210K 0.52% 50
2017
Q2
$21.5M Buy
165,696
+2,522
+2% +$309K 0.48% 52
2017
Q1
$20.3M Buy
163,174
+1,422
+0.9% +$170K 0.42% 67
2016
Q4
$18.7M Buy
161,752
+3,500
+2% +$390K 0.38% 74
2016
Q3
$16.5M Sell
158,252
-16,356
-9% -$1.77M 0.36% 76
2016
Q2
$17.2M Sell
174,608
-3,259
-2% -$337K 0.35% 76
2016
Q1
$17.8M Buy
177,867
+2,733
+2% +$281K 0.37% 76
2015
Q4
$21M Buy
175,134
+1,549
+0.9% +$179K 0.44% 63
2015
Q3
$18.8M Buy
173,585
+1,390
+0.8% +$172K 0.42% 69
2015
Q2
$19.9M Buy
+172,195
New +$19.7M 0.42% 74
2013
Q4
Sell
-932
Closed -$71.8K 401
2013
Q3
$71.8K Hold
932
﹤0.01% 158
2013
Q2
$54.5K Buy
+932
New +$56.1K ﹤0.01% 222

Other funds holding CELG

Piedmont Investment Advisors's CELG Position: Q4 2019 in Review

Piedmont Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 120,529 shares — an estimated $12M sold.

Piedmont Investment Advisors first reported a position in CELG in Q2 2013 and held it in 20 quarters. The position peaked at $24.4M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Piedmont Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 120,529 Celgene Corp shares in Q4 2019, an estimated $12M.
  • Piedmont Investment Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 20 quarters.
  • Piedmont Investment Advisors's Celgene Corp position peaked at $24.4M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Piedmont Investment Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.